These findings uncovered a novel mechanism of contractile function enhancement solely due to cell volume increase in ASMC hypertrophy, which involved crosstalk between Piezo1 and YAP and, thus, might provide a potential therapeutic strategy for treating pulmonary diseases associated with ASMC hypertrophy by specifically targeting the cell’s Piezo1 channel. This evidence concerns the gene PIEZO1 and lung disorder.